Drug Testing Experts
The Food and Drug Administration has granted orphan drug designation for a cannabis-based drug developed to treat childhood-onset epilepsy.
Beginning November 18, 2024, State Drivers License Agencies (SDLAs) across the nation will be required to remove the commercial driving privileges of drivers in a
As 2023 comes to an end there are major events occurring to increase the number of tools employers have available to test for Delta-9 THC,
Beginning November 18, 2024 drivers with a “prohibited” status in the clearinghouse will lose their state commercial driving privileges directly reported from the FMCSA Clearinghouse.
The benefits of the FMCSA Drug and Alcohol Clearinghouse are especially evident for employers to assist them in researching potential new hire employment history. This
|
|
All Rights Reserved
|
